Table 4.
Comorbidity in patient groups and controls
| Comorbidity | Patients | Controls | Test | p value |
|---|---|---|---|---|
| Osteopenia/osteoporosis | 12 (22.2%) | 1 (1.9%) | χ2 =10,5 | 0.001 |
| Thyroid dysfunction | 18 (33.3%) | 6 (11.1%) | χ2 =7,7 | 0.005 |
| Blood diseases | 4 (7.4%) | 0 | Fisher's exact test | 0.049 |
| Heart diseases | 13 (24.1%) | 4 (7.5%) | χ2 =5,6 | 0.017 |
| Liver diseases | 12 (22.2%) | 0 | χ2 =13,5 | 0.0002 |
| Gastrointestinal diseases | 7 (13.0%) | 0 | Fisher's exact test | 0.006 |
| Hypovitaminosis | 4 (7.4%) | 1 (1.9%) | Fisher's exact test | > 0.05 |
| Kidney diseases | 3 (5.6%) | 1 (1.9%) | Fisher's exact test | > 0.05 |
| Dyslipidemia | 2 (3.7%) | 2 (3.7%) | Fisher's exact test | > 0.05 |
| Diabetes | 5 (9.3%) | 5 (9.3%) | χ2 =0 | > 0.05 |
| Lung diseases | 3 (5.6%) | 0 | Fisher's exact test | > 0.05 |
| Hypertension | 20 (37.0%) | 17 (31.5%) | χ2 =0,4 | > 0.05 |
| Diseases of the nervous system | 4 (7.4%) | 1 (1.9%) | Fisher's exact test | > 0.05 |
| Valvulopathy | 2 (3.7%) | 0 | Fisher's exact test | > 0.05 |
| Other comorbidities | 30 (55.6%) | 9 (16.7%) | χ2 =17,6 | 0.00002 |